141 related articles for article (PubMed ID: 31774209)
1. Improving the barrier function of damaged cultured urothelium using chondroitin sulfate.
Rozenberg BB; Janssen DAW; Jansen CFJ; Schalken JA; Heesakkers JPFA
Neurourol Urodyn; 2020 Feb; 39(2):558-564. PubMed ID: 31774209
[TBL] [Abstract][Full Text] [Related]
2. Restoring the barrier of chronically damaged urothelium using chondroitin sulfate glycosaminoglycan-replenishment therapy.
Rozenberg BB; van Ginkel CJ; Janssen DAW
Curr Opin Urol; 2024 Mar; 34(2):44-51. PubMed ID: 37962190
[TBL] [Abstract][Full Text] [Related]
3. In the absence of overt urothelial damage, chondroitinase ABC digestion of the GAG layer increases bladder permeability in ovariectomized female rats.
Hurst RE; Van Gordon S; Tyler K; Kropp B; Towner R; Lin H; Marentette JO; McHowat J; Mohammedi E; Greenwood-Van Meerveld B
Am J Physiol Renal Physiol; 2016 May; 310(10):F1074-80. PubMed ID: 26911855
[TBL] [Abstract][Full Text] [Related]
4. The distribution and function of chondroitin sulfate and other sulfated glycosaminoglycans in the human bladder and their contribution to the protective bladder barrier.
Janssen DA; van Wijk XM; Jansen KC; van Kuppevelt TH; Heesakkers JP; Schalken JA
J Urol; 2013 Jan; 189(1):336-42. PubMed ID: 23174248
[TBL] [Abstract][Full Text] [Related]
5. Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.
Hauser PJ; Buethe DA; Califano J; Sofinowski TM; Culkin DJ; Hurst RE
J Urol; 2009 Nov; 182(5):2477-82. PubMed ID: 19765766
[TBL] [Abstract][Full Text] [Related]
6. Urinary glycosaminoglycans as biomarker for urothelial injury: is it possible to discriminate damage from recovery?
Soler R; Bruschini H; Martins JR; Dreyfuss JL; Camara NO; Alves MT; Leite KR; Truzzi JC; Nader HB; Srougi M; Ortiz V
Urology; 2008 Oct; 72(4):937-42. PubMed ID: 18314179
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities in Expression of Structural, Barrier and Differentiation Related Proteins, and Chondroitin Sulfate in Feline and Human Interstitial Cystitis.
Hauser PJ; VanGordon SB; Seavey J; Sofinowski TM; Ramadan M; Abdullah S; Buffington CA; Hurst RE
J Urol; 2015 Aug; 194(2):571-7. PubMed ID: 25636658
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitis.
Rooney P; Srivastava A; Watson L; Quinlan LR; Pandit A
Acta Biomater; 2015 Jun; 19():66-75. PubMed ID: 25818949
[TBL] [Abstract][Full Text] [Related]
9. [Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model].
Schulz A; Vestweber AM; Dressler D
Aktuelle Urol; 2009 Mar; 40(2):109-12. PubMed ID: 19296424
[TBL] [Abstract][Full Text] [Related]
10. Urine is necessary to provoke bladder inflammation in protamine sulfate induced urothelial injury.
Soler R; Bruschini H; Freire MP; Alves MT; Srougi M; Ortiz V
J Urol; 2008 Oct; 180(4):1527-31. PubMed ID: 18710775
[TBL] [Abstract][Full Text] [Related]
11. Bladder permeability barrier: recovery from selective injury of surface epithelial cells.
Lavelle J; Meyers S; Ramage R; Bastacky S; Doty D; Apodaca G; Zeidel ML
Am J Physiol Renal Physiol; 2002 Aug; 283(2):F242-53. PubMed ID: 12110507
[TBL] [Abstract][Full Text] [Related]
12. A high molecular weight hyaluronic acid biphasic dispersion as potential therapeutics for interstitial cystitis.
Rooney PR; Kannala VK; Kotla NG; Benito A; Dupin D; Loinaz I; Quinlan LR; Rochev Y; Pandit A
J Biomed Mater Res B Appl Biomater; 2021 Jun; 109(6):864-876. PubMed ID: 33103826
[TBL] [Abstract][Full Text] [Related]
13. UPK3A
Peng L; Chen JW; Chen YZ; Zhang C; Shen SH; Liu MZ; Fan Y; Yang SQ; Zhang XZ; Wang W; Gao XS; Di XP; Ma YC; Zeng X; Shen H; Jin X; Luo DY
J Pathol; 2024 Jun; 263(2):203-216. PubMed ID: 38551071
[TBL] [Abstract][Full Text] [Related]
14. GAG replenishment therapy for bladder pain syndrome/interstitial cystitis.
Wyndaele JJJ; Riedl C; Taneja R; Lovász S; Ueda T; Cervigni M
Neurourol Urodyn; 2019 Feb; 38(2):535-544. PubMed ID: 30592544
[TBL] [Abstract][Full Text] [Related]
15. Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis.
Engles CD; Hauser PJ; Abdullah SN; Culkin DJ; Hurst RE
Urology; 2012 Feb; 79(2):483.e13-7. PubMed ID: 22137543
[TBL] [Abstract][Full Text] [Related]
16. Generation of a functional, differentiated porcine urothelial tissue in vitro.
Turner AM; Subramaniam R; Thomas DF; Southgate J
Eur Urol; 2008 Dec; 54(6):1423-32. PubMed ID: 18395964
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder.
Çetinel S; Çanıllıoğlu YE; Çikler E; Sener G; Ercan F
BJU Int; 2011 Apr; 107(8):1320-5. PubMed ID: 20735385
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.
Slobodov G; Feloney M; Gran C; Kyker KD; Hurst RE; Culkin DJ
J Urol; 2004 Apr; 171(4):1554-8. PubMed ID: 15017219
[TBL] [Abstract][Full Text] [Related]
19. Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®).
Costantini E; Lazzeri M; Pistolesi D; Del Zingaro M; Frumenzio E; Boni A; Pietropaolo A; Fragalà E; Porena M
Urol Int; 2013; 91(1):81-8. PubMed ID: 23485915
[TBL] [Abstract][Full Text] [Related]
20. Correlative study of functional and structural regeneration of urothelium after chitosan-induced injury.
Erman A; Kerec Kos M; Žakelj S; Resnik N; Romih R; Veranič P
Histochem Cell Biol; 2013 Nov; 140(5):521-31. PubMed ID: 23553328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
